Plasma levels of oxybutynine chloride in children View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1994-02

AUTHORS

E. Autret, A. P. Jonville, J. P. Dutertre, M. C. Bertiere, M. Robert, M. Averous, W. Couet

ABSTRACT

Anticholinergic adverse-effects in children treated with conventional doses of oxybutynine led us to measure plasma oxybutynine levels in children. 18 children, aged 5 to 13 y, who required treatment with oxybutynine chloride for daytime incontinence were studied. Plasma concentrations were measured on the fifth day of a course of treatment in which the dose was adapted to the child's body weight; the dose was given twice daily at 12-hour intervals. In 10 children aged between 5 and 8 y, the mean dose was 0.1 mg · kg−1. In 8 children aged between 10 and 13 years, the mean dose was 0.15 mg · kg−1.The highest concentration was usually found between 1 and 2 h after administration. The subsequent fall in concentration was rapid and after 6 h oxybutynine was no longer measurable in 14 of the children. The concentrations found were not different from those seen in adults given equivalent doses.The results show that plasma concentrations in children were not very different from those observed in adults if the dose were adapted to the body weight of the children. No special differences in paediatric use were revealed that might explain the particular adverse-effects. The results of the study argue against the dosage regimen proposed before these adverse events were detected. They strongly favour a dose adapted to the body weight of the child, with a 12-hour interval between doses. More... »

PAGES

83-85

References to SciGraph publications

  • 1988-09. The pharmacokinetics of oxybutynin in man in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/bf00195921

    DOI

    http://dx.doi.org/10.1007/bf00195921

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1045421711

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/8005192


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Public Health and Health Services", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adolescent", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aging", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Body Weight", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Child", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Child, Preschool", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mandelic Acids", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Parasympatholytics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Urinary Incontinence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Urination Disorders", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Clinical Pharmacology, University Hospital of Tours, France", 
              "id": "http://www.grid.ac/institutes/grid.411167.4", 
              "name": [
                "Department of Clinical Pharmacology, University Hospital of Tours, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Autret", 
            "givenName": "E.", 
            "id": "sg:person.01233433262.98", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233433262.98"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Clinical Pharmacology, University Hospital of Tours, France", 
              "id": "http://www.grid.ac/institutes/grid.411167.4", 
              "name": [
                "Department of Clinical Pharmacology, University Hospital of Tours, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jonville", 
            "givenName": "A. P.", 
            "id": "sg:person.01363001012.66", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01363001012.66"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Dutertre", 
            "givenName": "J. P.", 
            "id": "sg:person.010471522024.26", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010471522024.26"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "DEBAT Laboratories, Tours, France", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "DEBAT Laboratories, Tours, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bertiere", 
            "givenName": "M. C.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Paediatric Surgery, University Hospital of Tours, France", 
              "id": "http://www.grid.ac/institutes/grid.411167.4", 
              "name": [
                "Paediatric Surgery, University Hospital of Tours, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Robert", 
            "givenName": "M.", 
            "id": "sg:person.076154314.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.076154314.38"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Paediatric Surgery, Montepllier University Hospital, Tours, France", 
              "id": "http://www.grid.ac/institutes/grid.411167.4", 
              "name": [
                "Department of Paediatric Surgery, Montepllier University Hospital, Tours, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Averous", 
            "givenName": "M.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Clinical Pharmacology, University Hospital of Tours, France", 
              "id": "http://www.grid.ac/institutes/grid.411167.4", 
              "name": [
                "Department of Clinical Pharmacology, University Hospital of Tours, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Couet", 
            "givenName": "W.", 
            "id": "sg:person.01174625422.59", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174625422.59"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/bf00558247", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051113053", 
              "https://doi.org/10.1007/bf00558247"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1994-02", 
        "datePublishedReg": "1994-02-01", 
        "description": "Anticholinergic adverse-effects in children treated with conventional doses of oxybutynine led us to measure plasma oxybutynine levels in children. 18 children, aged 5 to 13 y, who required treatment with oxybutynine chloride for daytime incontinence were studied. Plasma concentrations were measured on the fifth day of a course of treatment in which the dose was adapted to the child's body weight; the dose was given twice daily at 12-hour intervals. In 10 children aged between 5 and 8 y, the mean dose was 0.1 mg \u00b7 kg\u22121. In 8 children aged between 10 and 13 years, the mean dose was 0.15 mg \u00b7 kg\u22121.The highest concentration was usually found between 1 and 2 h after administration. The subsequent fall in concentration was rapid and after 6 h oxybutynine was no longer measurable in 14 of the children. The concentrations found were not different from those seen in adults given equivalent doses.The results show that plasma concentrations in children were not very different from those observed in adults if the dose were adapted to the body weight of the children. No special differences in paediatric use were revealed that might explain the particular adverse-effects. The results of the study argue against the dosage regimen proposed before these adverse events were detected. They strongly favour a dose adapted to the body weight of the child, with a 12-hour interval between doses.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/bf00195921", 
        "inLanguage": "en", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1054337", 
            "issn": [
              "0031-6970", 
              "1432-1041"
            ], 
            "name": "European Journal of Clinical Pharmacology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "46"
          }
        ], 
        "keywords": [
          "body weight", 
          "mean dose", 
          "plasma concentrations", 
          "course of treatment", 
          "children's body weight", 
          "daytime incontinence", 
          "adverse events", 
          "conventional doses", 
          "dosage regimen", 
          "plasma levels", 
          "pediatric use", 
          "dose", 
          "equivalent doses", 
          "fifth day", 
          "doses", 
          "oxybutynine", 
          "children", 
          "subsequent fall", 
          "adults", 
          "treatment", 
          "incontinence", 
          "regimen", 
          "special difference", 
          "weight", 
          "administration", 
          "intervals", 
          "high concentrations", 
          "levels", 
          "concentration", 
          "days", 
          "years", 
          "course", 
          "fall", 
          "differences", 
          "study", 
          "events", 
          "results", 
          "use", 
          "chloride", 
          "plasma oxybutynine levels", 
          "oxybutynine levels", 
          "oxybutynine chloride"
        ], 
        "name": "Plasma levels of oxybutynine chloride in children", 
        "pagination": "83-85", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1045421711"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/bf00195921"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "8005192"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/bf00195921", 
          "https://app.dimensions.ai/details/publication/pub.1045421711"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-11-01T18:00", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_253.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/bf00195921"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00195921'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00195921'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00195921'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00195921'


     

    This table displays all metadata directly associated to this object as RDF triples.

    202 TRIPLES      22 PREDICATES      82 URIs      73 LITERALS      19 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/bf00195921 schema:about N1b07a41690374016bb038e893c24b24c
    2 N1c3b4322ff8c446db25dfe617cd17e82
    3 N21e160e0a0e543a78f4d05b4bdaa9090
    4 N36a81ed7c280410db4e102a04bb5ed47
    5 N7e17e5a1af184780b19ba19ea10c1dad
    6 N84f30d9a89ec4498b9befce6ad1784cf
    7 Na83cfccbf39d426183e7b9ea36728aa6
    8 Nc3373d0c692f4c789970c81c06146700
    9 Nd619d121c1cf43bcaac77daf260cd8de
    10 Nea9dd32669ef487399280187370b52fb
    11 Nfaf2a3a1e2034a8aacefcc89834d677e
    12 Nfff359dca9da4e7299d0955c99bcdd99
    13 anzsrc-for:11
    14 anzsrc-for:1117
    15 schema:author Nd6b398fec12f42ef8bd2443a1ba11c76
    16 schema:citation sg:pub.10.1007/bf00558247
    17 schema:datePublished 1994-02
    18 schema:datePublishedReg 1994-02-01
    19 schema:description Anticholinergic adverse-effects in children treated with conventional doses of oxybutynine led us to measure plasma oxybutynine levels in children. 18 children, aged 5 to 13 y, who required treatment with oxybutynine chloride for daytime incontinence were studied. Plasma concentrations were measured on the fifth day of a course of treatment in which the dose was adapted to the child's body weight; the dose was given twice daily at 12-hour intervals. In 10 children aged between 5 and 8 y, the mean dose was 0.1 mg · kg−1. In 8 children aged between 10 and 13 years, the mean dose was 0.15 mg · kg−1.The highest concentration was usually found between 1 and 2 h after administration. The subsequent fall in concentration was rapid and after 6 h oxybutynine was no longer measurable in 14 of the children. The concentrations found were not different from those seen in adults given equivalent doses.The results show that plasma concentrations in children were not very different from those observed in adults if the dose were adapted to the body weight of the children. No special differences in paediatric use were revealed that might explain the particular adverse-effects. The results of the study argue against the dosage regimen proposed before these adverse events were detected. They strongly favour a dose adapted to the body weight of the child, with a 12-hour interval between doses.
    20 schema:genre article
    21 schema:inLanguage en
    22 schema:isAccessibleForFree false
    23 schema:isPartOf N395fadcb202c491f86f4855106eb0ef0
    24 N4d32c3cee61a4948a6409509e6c5266e
    25 sg:journal.1054337
    26 schema:keywords administration
    27 adults
    28 adverse events
    29 body weight
    30 children
    31 children's body weight
    32 chloride
    33 concentration
    34 conventional doses
    35 course
    36 course of treatment
    37 days
    38 daytime incontinence
    39 differences
    40 dosage regimen
    41 dose
    42 doses
    43 equivalent doses
    44 events
    45 fall
    46 fifth day
    47 high concentrations
    48 incontinence
    49 intervals
    50 levels
    51 mean dose
    52 oxybutynine
    53 oxybutynine chloride
    54 oxybutynine levels
    55 pediatric use
    56 plasma concentrations
    57 plasma levels
    58 plasma oxybutynine levels
    59 regimen
    60 results
    61 special difference
    62 study
    63 subsequent fall
    64 treatment
    65 use
    66 weight
    67 years
    68 schema:name Plasma levels of oxybutynine chloride in children
    69 schema:pagination 83-85
    70 schema:productId N4173254fe8144ce2b8d916e57f46c894
    71 N5e85785538584de8a9d75e993dac484f
    72 N65b49a165a7241299b8fee2e0bf35a9c
    73 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045421711
    74 https://doi.org/10.1007/bf00195921
    75 schema:sdDatePublished 2021-11-01T18:00
    76 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    77 schema:sdPublisher N1221a87f1db14b709eeb804f37793549
    78 schema:url https://doi.org/10.1007/bf00195921
    79 sgo:license sg:explorer/license/
    80 sgo:sdDataset articles
    81 rdf:type schema:ScholarlyArticle
    82 N1221a87f1db14b709eeb804f37793549 schema:name Springer Nature - SN SciGraph project
    83 rdf:type schema:Organization
    84 N1b07a41690374016bb038e893c24b24c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    85 schema:name Aging
    86 rdf:type schema:DefinedTerm
    87 N1c3b4322ff8c446db25dfe617cd17e82 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    88 schema:name Adolescent
    89 rdf:type schema:DefinedTerm
    90 N21e160e0a0e543a78f4d05b4bdaa9090 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    91 schema:name Body Weight
    92 rdf:type schema:DefinedTerm
    93 N333384d9c7e74b13b0e9fc83181b983b rdf:first sg:person.010471522024.26
    94 rdf:rest N372d0e3daf404cbe90abcf5d71721335
    95 N36a81ed7c280410db4e102a04bb5ed47 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    96 schema:name Child, Preschool
    97 rdf:type schema:DefinedTerm
    98 N372d0e3daf404cbe90abcf5d71721335 rdf:first N831524a1f1964c45b7d9e6a194407941
    99 rdf:rest N58ab3f670efe446295d4cb75d9c89181
    100 N395fadcb202c491f86f4855106eb0ef0 schema:issueNumber 1
    101 rdf:type schema:PublicationIssue
    102 N4173254fe8144ce2b8d916e57f46c894 schema:name doi
    103 schema:value 10.1007/bf00195921
    104 rdf:type schema:PropertyValue
    105 N4d32c3cee61a4948a6409509e6c5266e schema:volumeNumber 46
    106 rdf:type schema:PublicationVolume
    107 N58ab3f670efe446295d4cb75d9c89181 rdf:first sg:person.076154314.38
    108 rdf:rest N9eb6c9435b004efc99a347b395e65eaf
    109 N5e85785538584de8a9d75e993dac484f schema:name pubmed_id
    110 schema:value 8005192
    111 rdf:type schema:PropertyValue
    112 N65b49a165a7241299b8fee2e0bf35a9c schema:name dimensions_id
    113 schema:value pub.1045421711
    114 rdf:type schema:PropertyValue
    115 N7e17e5a1af184780b19ba19ea10c1dad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    116 schema:name Female
    117 rdf:type schema:DefinedTerm
    118 N831524a1f1964c45b7d9e6a194407941 schema:affiliation grid-institutes:None
    119 schema:familyName Bertiere
    120 schema:givenName M. C.
    121 rdf:type schema:Person
    122 N84f30d9a89ec4498b9befce6ad1784cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Humans
    124 rdf:type schema:DefinedTerm
    125 N9eb6c9435b004efc99a347b395e65eaf rdf:first Nb9553a5b972f4b48a01e3918574f96e3
    126 rdf:rest Na572792029da44b49555dbc905035010
    127 Na572792029da44b49555dbc905035010 rdf:first sg:person.01174625422.59
    128 rdf:rest rdf:nil
    129 Na83cfccbf39d426183e7b9ea36728aa6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    130 schema:name Parasympatholytics
    131 rdf:type schema:DefinedTerm
    132 Nb9553a5b972f4b48a01e3918574f96e3 schema:affiliation grid-institutes:grid.411167.4
    133 schema:familyName Averous
    134 schema:givenName M.
    135 rdf:type schema:Person
    136 Nc3373d0c692f4c789970c81c06146700 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Urinary Incontinence
    138 rdf:type schema:DefinedTerm
    139 Nd619d121c1cf43bcaac77daf260cd8de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    140 schema:name Male
    141 rdf:type schema:DefinedTerm
    142 Nd6b398fec12f42ef8bd2443a1ba11c76 rdf:first sg:person.01233433262.98
    143 rdf:rest Nf474f46031d6464399cc21e37a41dbc1
    144 Nea9dd32669ef487399280187370b52fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Mandelic Acids
    146 rdf:type schema:DefinedTerm
    147 Nf474f46031d6464399cc21e37a41dbc1 rdf:first sg:person.01363001012.66
    148 rdf:rest N333384d9c7e74b13b0e9fc83181b983b
    149 Nfaf2a3a1e2034a8aacefcc89834d677e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name Urination Disorders
    151 rdf:type schema:DefinedTerm
    152 Nfff359dca9da4e7299d0955c99bcdd99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    153 schema:name Child
    154 rdf:type schema:DefinedTerm
    155 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    156 schema:name Medical and Health Sciences
    157 rdf:type schema:DefinedTerm
    158 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
    159 schema:name Public Health and Health Services
    160 rdf:type schema:DefinedTerm
    161 sg:journal.1054337 schema:issn 0031-6970
    162 1432-1041
    163 schema:name European Journal of Clinical Pharmacology
    164 schema:publisher Springer Nature
    165 rdf:type schema:Periodical
    166 sg:person.010471522024.26 schema:familyName Dutertre
    167 schema:givenName J. P.
    168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010471522024.26
    169 rdf:type schema:Person
    170 sg:person.01174625422.59 schema:affiliation grid-institutes:grid.411167.4
    171 schema:familyName Couet
    172 schema:givenName W.
    173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174625422.59
    174 rdf:type schema:Person
    175 sg:person.01233433262.98 schema:affiliation grid-institutes:grid.411167.4
    176 schema:familyName Autret
    177 schema:givenName E.
    178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233433262.98
    179 rdf:type schema:Person
    180 sg:person.01363001012.66 schema:affiliation grid-institutes:grid.411167.4
    181 schema:familyName Jonville
    182 schema:givenName A. P.
    183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01363001012.66
    184 rdf:type schema:Person
    185 sg:person.076154314.38 schema:affiliation grid-institutes:grid.411167.4
    186 schema:familyName Robert
    187 schema:givenName M.
    188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.076154314.38
    189 rdf:type schema:Person
    190 sg:pub.10.1007/bf00558247 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051113053
    191 https://doi.org/10.1007/bf00558247
    192 rdf:type schema:CreativeWork
    193 grid-institutes:None schema:alternateName DEBAT Laboratories, Tours, France
    194 schema:name DEBAT Laboratories, Tours, France
    195 rdf:type schema:Organization
    196 grid-institutes:grid.411167.4 schema:alternateName Department of Clinical Pharmacology, University Hospital of Tours, France
    197 Department of Paediatric Surgery, Montepllier University Hospital, Tours, France
    198 Paediatric Surgery, University Hospital of Tours, France
    199 schema:name Department of Clinical Pharmacology, University Hospital of Tours, France
    200 Department of Paediatric Surgery, Montepllier University Hospital, Tours, France
    201 Paediatric Surgery, University Hospital of Tours, France
    202 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...